Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway.
D000818:Animals; D001519:Behavior / Q000187:drug effects*; D003342:Corpus Striatum / Q000378:metabolism / Q000502:physiology*; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009416:Nerve Regeneration / Q000187:drug effects; D009434:Neural Pathways / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013239:Stereotyped Behavior / Q000187:drug effects*; D013378:Substantia Nigra / Q000378:metabolism / Q000502:physiology*; D013997:Time Factors
D006892:Hydroxydopamines; D008781:Methyltyrosines; D012110:Reserpine; D003913:Dextroamphetamine; D004298:Dopamine